Key result
Microplastics and nanoplastics drive cardiovascular disease risk via oxidative stress and mitochondrial damage.
Answers are grounded in this paper and cite their sources.
Microplastics and nanoplastics may contribute to cardiovascular disease pathogenesis through mitochondrial dysfunction, oxidative stress, and inflammation.
Microplastics and nanoplastics (MNPs) are becoming ubiquitous environmental pollutants, with increasing evidence of their systemic toxicity. MNPs are increasingly detected in human tissues, including the cardiovascular system, and have been implicated in the pathogenesis of cardiovascular disease through mitochondrial dysfunction. This review integrates mechanistic insights into how MNPs impair mitochondrial integrity, induce oxidative stress, disrupt calcium signaling, and promote genomic instability in cardiac tissue. MNPs also exacerbate inflammation, cellular senescence, mitophagy dysfunction, and pro-atherosclerotic remodeling. Furthermore, this review examines sex-specific mitochondrial responses and developmental vulnerabilities. Understanding the molecular crosstalk between MNPs exposure and mitochondrial damage may provide a foundation for targeted interventions to mitigate environmental cardiovascular risks.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) conducted a review in Cardiovascular disease. Microplastics and nanoplastics (MNPs) was evaluated. Microplastics and nanoplastics are implicated in cardiovascular disease pathogenesis by impairing mitochondrial integrity, inducing oxidative stress, and promoting pro-atherosclerotic remodeling.
Synapse has enriched 10 related papers. Consider them for comparative context: